Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

DNLIDNLI
Showing 8 of 26 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in DENALI THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 3.7M shares of DNLI (DENALI THERAPEUTICS INC), worth $96M as of 2026-Q2. The position was increased (+0.1% shares). DNLI represents 0.5% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$96M

Current Shares

3.7M

Total Value Change

-$12.7M

Total Shares Change

+2,641

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.7M
+0.1%
$96M0.5%$25.72
36
2026-Q1
Unchanged
3.7M
0.0%
$71.6M0.4%$20.02
0
2025-Q4
Unchanged
3.7M
0.0%
$61.6M0.4%$16.41
0
2025-Q3
Unchanged
3.7M
0.0%
$54.2M0.4%$14.52
0
2025-Q2
Unchanged
3.7M
0.0%
$52.2M0.5%$14.10
0
2025-Q1
Unchanged
3.7M
0.0%
$50.7M0.6%$14.78
0
2024-Q4
Unchanged
3.7M
0.0%
$76.1M0.8%$20.24
0
2024-Q3
Unchanged
3.7M
0.0%
$108.7M1.1%$29.43
0

Other major holders of DNLI: BAILLIE GIFFORD & CO, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used